Table 2.
Relationship between EIF3B expression and tumor characteristics in patients with pancreatic cancer.
| Features | No. of patients | EIF3B expression | P-value | |
|---|---|---|---|---|
| Low | High | |||
| All patients | 97 | 62 | 35 | |
| Age (years) | 0.833 | |||
| ≤59 | 48 | 30 | 18 | |
| >59 | 48 | 31 | 17 | |
| Gender | 0.660 | |||
| Male | 61 | 40 | 21 | |
| Female | 36 | 22 | 14 | |
| Lymph node positive | 0.055 | |||
| =0 | 47 | 25 | 22 | |
| >0 | 41 | 30 | 11 | |
| Tumor size | 0.825 | |||
| ≤4 cm | 59 | 38 | 21 | |
| >4 cm | 37 | 23 | 14 | |
| Grade | 0.007 | |||
| II | 66 | 48 | 18 | |
| III | 30 | 14 | 16 | |
| IV | 1 | 0 | 1 | |
| Stage | 0.303 | |||
| 1 | 37 | 21 | 16 | |
| 2 | 55 | 38 | 17 | |
| 4 | 2 | 1 | 1 | |
| T Infiltrate | 0.918 | |||
| T1 | 3 | 2 | 1 | |
| T2 | 73 | 46 | 27 | |
| T3 | 20 | 13 | 7 | |
| Lymphatic metastasis (N) | 0.092 | |||
| N0 | 50 | 28 | 22 | |
| N1 | 41 | 30 | 11 | |
| History of diabetes | 0.514 | |||
| No | 5 | 4 | 1 | |
| Yes | 61 | 40 | 21 | |